Index Entries

Sheila F. Lumley, Deise O’Donnell, Nicole E. Stoesser, Philippa C. Matthews, Alison Howarth, Stephanie B. Hatch, Brian D. Marsden, Stuart Cox, Tim James, Fiona Warren, Liam J. Peck, Thomas G. Ritter, Zoe de Toledo, Laura Warren, David Axten, Richard J. Cornall, E. Yvonne Jones, David I. Stuart, Gavin Screaton, Daniel Ebner, Sarah Hoosdally, Meera Chand, Derrick W. Crook, Anne-Marie O’Donnell, Christopher P. Conlon, Koen B. Pouwels, A. Sarah Walker, Tim E.A. Peto, Susan Hopkins, Timothy M. Walker, Katie Jeffery, and David W. Eyre
February 11, 2021
New England Journal of Medicine (NEJM)
University of Oxford (Hospitals Staff Testing Group)

Methods: We investigated the incidence of SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) in seropositive and seronegative health care workers attending testing of asymptomatic and symptomatic staff at Oxford University Hospitals in the United Kingdom. Baseline antibody status was determined by anti-spike (primary analysis) and anti-nucleocapsid IgG assays, and staff members were followed for up to 31 weeks…
 
Results: A total of 12,541 health care workers participated and had anti-spike IgG measured; 11,364 were followed up after negative antibody results and 1265 after positive results... There were no symptomatic infections in workers with anti-spike antibodies
 
Conclusions: The presence of anti-spike or anti-nucleocapsid IgG antibodies was associated with a substantially reduced risk of SARS-CoV-2 reinfection in the ensuing 6 months.”

document
natural immunity